Pharmacy Management and Specialty Pharmacies

So You Want To Build A 340B Specialty Pharmacy. How Hard Can It Be?

Proxsys Rx

JULY 1, 2025

Fair Warning: If you ever dismissively ask that question (above) of someone who’s led the planning and launch of a 340B hospital’s specialty pharmacy, and did it with no outside support, there’s a good chance you’ll get punched. POST OUTLINE Why is it so hard to build a 340B specialty pharmacy? Yes, it’s that difficult.

Specialty Pharmacies

Specialty Pharmacies Hospitals Pharmacy Management

So You Want To Build A 340B Specialty Pharmacy. How Hard Can It Be?

Proxsys Rx

DECEMBER 30, 2024

Fair Warning: If you ever dismissively ask that question of someone whos led the planning and launch of a 340B hospitals specialty pharmacy, and did it with no outside support, theres a good chance youll get punched. WHY is it so hard to build a 340B specialty pharmacy? Yes, its that difficult.

Specialty Pharmacies

Specialty Pharmacies Hospitals Pharmacy Management

Experts Discuss Specialty Pharmacy Accreditation, Re-Accreditation

Pharmacy Times

DECEMBER 22, 2022

Stephen Davis, PharmD, senior director of Health System Strategy at Shields, and Erica Diamantides, PharmD, specialty pharmacy manager at UW Medicine, discuss the current guidance and best practice for specialty pharmacy accreditations.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Management

Experts: Pharmacists Are Accessible and Valuable Resources in Arthritis Management

Pharmacy Times

AUGUST 9, 2024

A clinical pharmacy specialist and specialty pharmacy manager from Allegheny Health Network urge patients to use their pharmacist in the treatment management of arthritis.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Management

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Pharmacy Times

JUNE 8, 2025

Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role. The position ensures continuous care coordination and medication oversight across the system’s specialty pharmacy and neurology practices. 1 Evidence from recent studies supports the effectiveness of this approach.

So You Want To Build A 340B Specialty Pharmacy. How Hard Can It Be?

So You Want To Build A 340B Specialty Pharmacy. How Hard Can It Be?

Trending Sources

Experts Discuss Specialty Pharmacy Accreditation, Re-Accreditation

Experts: Pharmacists Are Accessible and Valuable Resources in Arthritis Management

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Spring 2025 Quiz: Test Your Pharmacy Knowledge!

10 Opportunities to Leverage for Career Advancement

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Advancing Pericarditis Care: The Evolving Role of IL-1 Inhibition and Pharmacist-Cardiologist Collaboration

McKesson Corporation Completes Acquisition of Core Ventures

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

OTC Case Studies: Summer Skin Care

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Stay Connected